U. S. Kim Et Al. , "The Suppressive Effect of Leucine-Rich Glioma Inactivated 3 (LGI3) Peptide on Impaired Skin Barrier Function in a Murine Model Atopic Dermatitis," PHARMACEUTICS , vol.12, no.8, 2020
Kim, U. S. Et Al. 2020. The Suppressive Effect of Leucine-Rich Glioma Inactivated 3 (LGI3) Peptide on Impaired Skin Barrier Function in a Murine Model Atopic Dermatitis. PHARMACEUTICS , vol.12, no.8 .
Kim, U. S., Park, J. W., Park, E. S., Bang, J. S., Jung, T. W., Kim, D., ... Abd El-Aty, A. M.(2020). The Suppressive Effect of Leucine-Rich Glioma Inactivated 3 (LGI3) Peptide on Impaired Skin Barrier Function in a Murine Model Atopic Dermatitis. PHARMACEUTICS , vol.12, no.8.
Kim, Ui Et Al. "The Suppressive Effect of Leucine-Rich Glioma Inactivated 3 (LGI3) Peptide on Impaired Skin Barrier Function in a Murine Model Atopic Dermatitis," PHARMACEUTICS , vol.12, no.8, 2020
Kim, Ui S. Et Al. "The Suppressive Effect of Leucine-Rich Glioma Inactivated 3 (LGI3) Peptide on Impaired Skin Barrier Function in a Murine Model Atopic Dermatitis." PHARMACEUTICS , vol.12, no.8, 2020
Kim, U. S. Et Al. (2020) . "The Suppressive Effect of Leucine-Rich Glioma Inactivated 3 (LGI3) Peptide on Impaired Skin Barrier Function in a Murine Model Atopic Dermatitis." PHARMACEUTICS , vol.12, no.8.
@article{article, author={Ui Seok Kim Et Al. }, title={The Suppressive Effect of Leucine-Rich Glioma Inactivated 3 (LGI3) Peptide on Impaired Skin Barrier Function in a Murine Model Atopic Dermatitis}, journal={PHARMACEUTICS}, year=2020}